GlaxoSmithKline plc (GSK) has gained Wednesday morning, with the stock adding 0.83% in pre-market trading to 42.73. GSK's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 107 out of 146 industries, the stock ranks higher than 97% of stocks. GlaxoSmithKline plc has fallen 2.55% over the past month, closing at $43.18 on November 10. During this period of time, the stock fell as low as $41.02 and as high as $43.54. GSK has an average analyst recommendation of Buy. The company has an average price target of $47.75.
GSK has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on GSK!